The Cigna Group (XTER:CGN) Other Noninterest Expense


XTER:CGN The Cigna Group XTER:CGN
53 GF Score
Price €248.00
GF Value €367.76
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is The Cigna Group Other Noninterest Expense?

Other Noninterest Expense (Bank) only applys to banks.

XTER:CGN
53GF Score
The Cigna Group XTER:CGN
Other Noninterest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is The Cigna Group (XTER:CGN) Overvalued in 2026?

Based on GuruFocus' analysis, The Cigna Group stock appears to be undervalued. The current stock price of €248.00 is trading 32.6% below its estimated GF Value™ of €367.76. GuruFocus considers The Cigna Group to be Significantly Undervalued.

Key valuation signals for XTER:CGN:

  • Other Noninterest Expense:
  • GF Value™: €367.76 vs. price of €248.00 (32.6% below fair value)
  • GF Score™: 53/100 with 4 warning signs

No single metric tells the full story. See the XTER:CGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

The Cigna Group Business Description

Address 900 Cottage Grove Road, Bloomfield, CT, USA, 06002
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
53GF Score

Get the complete analysis for XTER:CGN

Other Noninterest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€248.00
Price
€367.76
GF Value